What Researchers Did
The researchers describe a planned pilot trial that compares 20 sessions of hyperbaric oxygen with 20 sessions of a placebo gas in adults who still have symptoms after a concussion.
What They Found
This abstract describes the design of a randomized, double-blinded pilot trial of hyperbaric oxygen therapy for post-concussion syndrome, and it reports no results yet. The study plans to enroll 100 adults who still have symptoms 3-12 months after injury. The HBOT group would get 20 sessions of 100% oxygen at 2.0 ATA. The placebo group would get 20 sessions of 10.5% oxygen and 89.5% nitrogen at 2.0 ATA, which mimics the oxygen level of room air. The main outcome is the change in symptoms on the Rivermead Post-concussion Questionnaire. Secondary outcomes are adverse events, quality of life and cognitive function.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes only the plan for a pilot study with no results, so it cannot show whether HBOT works or is safe for post-concussion syndrome.